svc-ban2
DIGITAL HISTOLOGY
SERVICES
数字病理

Al Analysis

Advancing Structured R&D for Core Competitiveness in AI Pathology
Structured research and development (R&D) forms the foundation of core competitiveness in AI-driven pathology. Significant progress has been achieved in structured R&D for experimental rats and mice, enabling advanced AI-based tissue recognition, quantitative analysis, and diagnosis support.
Structured R&D Achievements
Experimental Rats

• AI can identify 262 basic tissue structures across 47 organ types.

• A total of 595 quantitative indicators can be computed for detailed analysis.


Experimental Mice

• AI can recognize 247 basic tissue structures across 48 organ types.

• A total of 567 quantitative indicators are available for analysis.


This structured R&D supports the diagnosis of over 100 common diseases per species, showcasing its broad applicability. (Note: Data anonymization or fuzzy processing may be applied to ensure privacy and security.)

原图 标记图
原图
标记图
Full Organ Recognition: Automating Analysis

To enhance analytical automation, AI algorithms for full organ recognition have been developed for both rats and mice. These algorithms:


• Automatically detect the location and type of organs in pathological sections.

• Link directly to basic structure recognition models, improving accuracy.

• Eliminate the need for manual selection of organ-specific models, achieving fully automated analysis.


The system recognizes 47 rat organs and 48 mouse organs with a recognition accuracy of 95% or higher for each organ type.

17345724246252893 3B9EB028-207A-4e46-BFA9-DD5306BF4E1C
17345724246252893
3B9EB028-207A-4e46-BFA9-DD5306BF4E1C
Improved Scanning Quality Detection

High-quality digital scans are essential for reliable AI analysis of pathological slides. To address issues such as blur caused by dirt, improper lighting, or focus errors during digitization:


• A slice scanning quality detection algorithm was developed.

• The algorithm identifies and marks blurred regions and highlights slides with scanning quality issues, reducing the need for manual inspections.

• Administrators can focus only on flagged slides, significantly lowering the quality inspection workload.


The detection algorithm achieves a 90% detection rate and a 92% accuracy rate, ensuring reliable input for AI-driven analyses.

17345724246252893 3B9EB028-207A-4e46-BFA9-DD5306BF4E1C
17345724246252893
3B9EB028-207A-4e46-BFA9-DD5306BF4E1C
Low-Cost Deployment for Practical AI Implementation

To make AI integration feasible in large-scale industrial settings, balancing performance with cost-efficiency is critical.


• Research demonstrated that using small parameter models, low video memory graphics cards, and compact memory cards delivers competitive results without compromising accuracy.

• All developed AI algorithms have been optimized for lightweight deployment, making them compatible with relatively low-cost hardware devices.


This approach ensures the cost-effectiveness of implementation, paving the way for widespread adoption of AI in pathology.

9k=
Conclusion

By leveraging structured R&D, full organ recognition, quality detection, and cost-efficient deployment, this AI platform provides a comprehensive solution for automated pathology analysis.

These advancements improve diagnostic precision, streamline workflows, and enhance the feasibility of integrating AI into routine and large-scale pathology applications.

Z